{
event: "view_event",
interaction_type: "calendar",
name: `European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE)`,
event_type: `3rd Party Registration`,
event_category: 'Congress',
date: `May 13, 2025, 9:55:00 AM - May 13, 2025, 10:25:00 AM`,
}
Successfully Registered.
Registration Failed
Congress
European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE)
1 hours
The symposium "A GLOBAL LENS ON T1D SCREENING: Local Actions, Global Impact" explored the benefits of early detection of presymptomatic T1D, and discussed practical insights from ongoing T1D screening programs that can support clinicians in screening for early-stage T1D in their daily practice.
A GLOBAL LENS ON T1D SCREENING: Local Actions, Global Impact
AGENDA
09:55–10:00 - Welcome
10:00–10:05 - A Global Perspective: The Power of Early Detection in T1D
10:05–10:20 - Local Action, Global Impact: Conversations on Screening Programs in T1D
10:20–10:25 - Q&A and Close
MEETING OBJECTIVES
Explore the benefits of early detection of people with presymptomatic T1D
Discuss practical insights from ongoing T1D screening programs
SYMPOSIUM OVERVIEW
Join our symposium "A GLOBAL LENS ON T1D SCREENING: Local Actions, Global Impact". This symposium will explore the benefits of early detection of presymptomatic T1D, and discuss practical insights from ongoing T1D screening programs that can support clinicians in screening for early-stage T1D in their daily practice.
MAT-GLB-2501243-1.0 - 03/2025
Welcome to BR1DGE
BR1DGE is a non-promotional global medical education program designed to advance understanding around presymptomatic type 1 diabetes and is provided by Sanofi.
This website is intended only for use by healthcare professionals in Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany, India, Ireland, Israel, Italy, Japan, Kingdom of Saudi Arabia, Kuwait, Luxembourg, Mexico, Norway, Poland, Portugal, Qatar, Russian Federation, Spain, Sweden, The Netherlands, The United Arab Emirates, and The United Kingdom (UK).
Note: Healthcare professionals from Ireland or The UK must click the second link below to be redirected to the local website.
Are you a healthcare professional from one of the countries listed above?
You are now being redirected to a third-party website.
You are now being redirected to a third-party website.
You are about to leave the Sanofi-sponsored BR1DGE website and enter a third-party website. This link is provided as a service and does not imply endorsement by Sanofi of the information contained on the third-party website. Sanofi is not responsible for the content, views, or privacy policies of this third-party site.
.png/jcr:content/hero%20-%20ESPE-ESE%20(2).png)
.png/jcr:content/hero%20-%20ESPE-ESE%20(2).png)